Dalbavancin (Intravenous Route)

Name: Dalbavancin (Intravenous Route)


Appropriate studies have not been performed on the relationship of age to the effects of dalbavancin injection in the pediatric population. Safety and efficacy have not been established.


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dalbavancin injection in the elderly. However, elderly patients are more likely to have unwanted side effects and age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving dalbavancin injection.